FP-21399

N/A

Report date: 2023/10/25 09:13:00

NME

Base Information

Drug NameFP-21399

Drug Alias NameFP-21399

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHIV envelope protein gp120 inhibitors

TargetsHIV envelope protein gp120

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLexigen

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesLexigen

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A